Newsroom

Takeda Corporate Information

To learn about our parent company, Takeda Pharmaceutical Company Limited, please visit http://www.takeda.com/

Media Inquiries

Please contact us at US.corporatecommunications@takeda.com or (224) 554-5499.

Recent News Releases

July 22, 2019 7/22/2019 Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohn's Disease
May 19, 2019 5/19/2019 New Exploratory Data from VARSITY, the First Head-to-Head Ulcerative Colitis Biologic Study Which Demonstrated Superiority of Vedolizumab to Adalimumab in Clinical Remission at Week 52, Presented at 2019 Digestive Disease Week®
May 17, 2019 5/17/2019 U.S. FDA Approves GATTEX® (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
May 16, 2019 5/16/2019 Takeda to Highlight Compelling New Data and Portfolio Advances for Gastrointestinal (GI) Diseases at DDW 2019
May 15, 2019 5/15/2019 Takeda to host two panel discussions on digital innovation showing promise in advancing treatment of depression at American Psychiatric Association Annual Meeting Innovation Zone

SEE ALL NEWS AND RELEASES >

Copyright 2014-2018 Takeda Pharmaceutical Company Limited. All rights reserved.

Certified Top Employer

 

You are about to leave www.Takeda.com/en-us and be redirected to another Takeda domain.